600276

How is 600276 doing right now?

In plain terms: 600276 is 50% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

600276 (Jiangsu Hengrui Pharmaceuticals) is 50.0% below its historical peak. Tape reads in a severe drawdown, with the last trade at $47.03. A 35-60% drawdown is the territory where most retail investors capitulate. It's also where the highest-probability historical entries have clustered for resilient assets.

What history says at this drawdown

Across all available history, 600276 has spent enough trading days in the 55%-to-50% drawdown band to build a large sample (466 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for 600276

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to 600276's own volatility history. Severe drawdowns are where Dipsern's segmentation provides the most edge: ordinary base rates don't apply, but the asset's own history at this exact depth does. The forward-return distribution here is bimodal — either rapid recovery or continued decline.